These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9557626)

  • 1. Complement values in B chronic lymphocytic leukemia: prognostic significance and correlation with cell maturation stage.
    Shvidel L; Vorst E; Berrebi A
    Leukemia; 1998 Apr; 12(4):635-6. PubMed ID: 9557626
    [No Abstract]   [Full Text] [Related]  

  • 2. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid.
    Schenkein HA; Genco RJ
    J Periodontol; 1977 Dec; 48(12):778-84. PubMed ID: 338883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased complement levels in cryoglobulinemia as a marker of chronic lymphocytic leukemia progression in a nonagenarian patient].
    Gracia-Cazaña T; Pastushenko I; Morales-Moya AL; Grasa MP
    Rev Esp Geriatr Gerontol; 2014; 49(4):194-5. PubMed ID: 24629731
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factor I deficiency].
    Fujita T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):250-2. PubMed ID: 11212709
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there relationship between SARS-CoV-2 and the complement C3 and C4?
    Dheir H; Sipahi S; Yaylaci S; Köroğlu M; Erdem AF; Karabay O
    Turk J Med Sci; 2020 Jun; 50(4):687-688. PubMed ID: 32421281
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of Detecting Serum Complement C3 and C4 in Patients with Multiple Myeloma].
    Li CJ; Xia HL; Wu YM; Ding G; Xu DD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):472-476. PubMed ID: 30998156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of macrophage activation on the synthesis of complement components C2, C3, C4.
    Hartung HP; Zanker B; Bitter-Suermann D
    Adv Exp Med Biol; 1982; 155():525-9. PubMed ID: 7158498
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum complement factors in human acute pancreatitis.
    Lankisch PG; Koop H; Kaboth U
    Hepatogastroenterology; 1981 Oct; 28(5):261-3. PubMed ID: 7345008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thioester bond of C3.
    Levine RP; Dodds AW
    Curr Top Microbiol Immunol; 1990; 153():73-82. PubMed ID: 1688756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation produced by biomaterials.
    Chenoweth DE
    ASAIO Trans; 1986; 32(1):226-32. PubMed ID: 3490860
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
    Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
    Nikiforova TV; Kuznetsova NN; Vavilova LM
    Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement activation in glomerulonephritis.
    Baer D
    N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The covalent binding reaction of C3 and C4.
    Law SK
    Ann N Y Acad Sci; 1983; 421():246-58. PubMed ID: 6586101
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid phase enzyme linked immunosorbent assay for classical complement activation pathway.
    Rhen M
    J Clin Pathol; 1987 Feb; 40(2):237-9. PubMed ID: 2434532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.